Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Objective:
Parkinson disease (PD) is a neurodegenerative movement disorder that is increasing in prevalence especially as the population continues to age. This article provides an overview of the clinical presentation and evaluation for PD, genetic and environmental risk factors, and current treatments.
Latest Developments:
New treatments for motor symptoms of PD (eg, motor fluctuations, extending "on time"), including istradefylline and opicapone, have been approved. A subcutaneous pump to provide dopaminergic agents to patients is now available. Additionally, skin biopsy staining for α-synuclein has become a viable option for patients with diagnostic uncertainty of synucleinopathy.
Essential Points:
PD is a heterogeneous neurodegenerative movement disorder with many potential presentations. Both motor and nonmotor symptoms are present during the disease course, and symptomatic medication and advanced surgical techniques have the potential to improve quality of life. Patients living with PD may manifest improvement in symptoms and quality of life from behavioral, pharmacologic, and surgical interventions. There remains no clear intervention to modify the progression of PD.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Brainstem
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
Lysosomal Hydrolases
Peripheral Artery Disease I: Introduction

